Pancreatic Cancer Research

ResearcherTianjin Nankai HospitalNo recent work listed

Zhonglian Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5125-9851; OpenAlex author ID A5101902138. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: 1 paper

Papers 4

  1. miR-499a promotes PANC-1 cell proliferation by down-regulating PDCD4 expression in pancreatic ductal adenocarcinoma. First author PMID 32661474↗
  2. Expression and clinical significance of EGF and TGF-α in chronic pancreatitis and pancreatic cancer. First author DOI 10.23736/s0391-1977.17.02721-3↗
  3. Na+/H+ exchanger regulatory factor 1 overexpression suppresses the malignant phenotype of MIAPaCa-2 pancreatic adenocarcinoma cells by downregulating Akt phosp… Last author DOI 10.3892/ol.2018.8289↗
  4. Surgical treatment for locally advanced pancreatic cancer localized in the pancreatic body and tail (report of 11 cases). Co-author PMID 26064401↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianheng Bao · 3 shared papers, 2015–2020 · strength 0.39
  2. Xibo Zhang · 3 shared papers, 2015–2018 · strength 0.29
  3. Chengfei Hao · 2 shared papers, 2015–2018 · strength 0.15
  4. Haibo Wang · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.